|Denaro||53,72 x 1000|
|Lettera||53,74 x 2900|
|Min-Max giorno||53,52 - 54,30|
|Intervallo di 52 settimane||36,15 - 64,94|
|Beta (5 anni mensile)||0,30|
|Rapporto PE (ttm)||56,39|
|Prossima data utili||N/D|
|Rendimento e dividendo (forward)||1,40 (2,56%)|
|Data ex dividendo||13 ago 2020|
|Stima target 1A||59,73|
AstraZeneca’s shares fell more than 3% on Monday after vaccine efficacy results found an average 70% effectiveness in preventing the virus, a rate much lower compared with efficiency rates of above 90% among its two biggest rivals – Moderna and Pfizer.
Oil gained strong upside momentum and is trying to settle above the nearest resistance level at $43.
The company’s COVID-19 vaccine showed efficacy of up to 90%.